BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33227331)

  • 1. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
    Lee YH; Park HI; Chang WS; Choi JS
    Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
    Han M; Vakili MR; Soleymani Abyaneh H; Molavi O; Lai R; Lavasanifar A
    Mol Pharm; 2014 Aug; 11(8):2640-9. PubMed ID: 24811541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
    Bielski ER; Zhong Q; Brown M; da Rocha SR
    Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
    Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
    Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
    Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
    Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Construction of a Mitochondrial Targeting, Fluorescent Self-Reporting Drug-Delivery Platform for Combined Enhancement of Endogenous ROS Responsiveness.
    Li J; Wei YJ; Yang XL; Wu WX; Zhang MQ; Li MY; Hu ZE; Liu YH; Wang N; Yu XQ
    ACS Appl Mater Interfaces; 2020 Jul; 12(29):32432-32445. PubMed ID: 32573194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid conjugated glycol chitosan micelles for targeted delivery of doxorubicin: preparation and preliminary evaluation in vitro.
    Yu J; Xie X; Wu J; Liu Y; Liu P; Xu X; Yu H; Lu L; Che X
    J Biomater Sci Polym Ed; 2013; 24(5):606-20. PubMed ID: 23565871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.
    Yu J; Xie X; Zheng M; Yu L; Zhang L; Zhao J; Jiang D; Che X
    Int J Nanomedicine; 2012; 7():5079-90. PubMed ID: 23049255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity.
    Theodossiou TA; Sideratou Z; Katsarou ME; Tsiourvas D
    Pharm Res; 2013 Nov; 30(11):2832-42. PubMed ID: 23921486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.
    Biswas S; Dodwadkar NS; Deshpande PP; Torchilin VP
    J Control Release; 2012 May; 159(3):393-402. PubMed ID: 22286008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioreducible Poly(ethylene glycol)-Triphenylphosphonium Conjugate as a Bioactivable Mitochondria-Targeting Nanocarrier.
    Khatun Z; Choi YS; Kim YG; Yoon K; Nurunnabi M; Li L; Lee E; Kang HC; Huh KM
    Biomacromolecules; 2017 Apr; 18(4):1074-1085. PubMed ID: 28257184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery.
    Xu Y; Wang S; Chan HF; Liu Y; Li H; He C; Li Z; Chen M
    Int J Pharm; 2017 Apr; 522(1-2):21-33. PubMed ID: 28215509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
    Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.
    Kanwal U; Bukhari NI; Rana NF; Rehman M; Hussain K; Abbas N; Mehmood A; Raza A
    Int J Nanomedicine; 2019; 14():1-15. PubMed ID: 30587981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled nanoparticles composed of glycol chitosan-dequalinium for mitochondria-targeted drug delivery.
    Mallick S; Song SJ; Bae Y; Choi JS
    Int J Biol Macromol; 2019 Jul; 132():451-460. PubMed ID: 30930268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance.
    Li WQ; Wang Z; Hao S; He H; Wan Y; Zhu C; Sun LP; Cheng G; Zheng SY
    ACS Appl Mater Interfaces; 2017 May; 9(20):16793-16802. PubMed ID: 28481505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
    Yu N; Li G; Gao Y; Liu X; Ma S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials.
    Choi YS; Kwon K; Yoon K; Huh KM; Kang HC
    Int J Pharm; 2017 Mar; 520(1-2):195-206. PubMed ID: 28179191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.